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Purpose: To evaluate the long-term outcome of limbal stem cell 
transplantation for management of total limbal stem cell deficiency 
due to chemical burn. 
Patients and Methods: In this retrospective cross sectional study; 
records of patients with history of severe (grade III to IV) chemical 
burns who underwent limbal stem cell transplantation in Labbafinejad 
Medical Center, Tehran, Iran between 2006 and 2016 were reviewed 
and data including demographic characteristics, visual acuity, surgical 
interventions and outcomes were reported. 
Results: Fifty eyes of fifty patients with a history of conjunctival 
limbal autograft (N = 24) or keratolimbal allograft (N = 26) with at 
least 12-months follow-up were included. The overall 1-year and 
5-year survival were 100 % and 84.1 % for conjunctival limbal autograft 
and 80.4 % and 40 % for keratolimbal allograft, respectively (P  =  0.037). 
The 1-year and 5-year corneal graft survival were 93.3 % and 63.8 
% after conjunctival limbal autograft and 92 % and 38.4 % after kera-
tolimbal allograft (P = 0.005 for five year survival). There was a signif-
icant improvement in LogMAR BCVA (1.79 versus 2.17, P  <  0.001) 
in all patients with no statistically significant difference between the 
two groups. 
Conclusion: Severe chemical burn is associated with significant 
ocular morbidity and long-term prognosis is poor. Graft survival 
rate was significantly better in conjunctival limbal autograft compared 
to keratolimbal allograft when comparing the long-term outcome of 
limbal stem cell transplantation for management of total limbal 
stem cell deficiency due to chemical burn. 
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Introduction
Chemical ocular burn is a true medical emer-
gency with serious and potentially blinding 
acute and chronic complications and is a major 
cause of limbal stem cell deficiency (LSCD) 1,2. 
Damage to the limbal stem cells either by direct 
damage from the chemical agents or secondary 
to limbal ischemia caused by damage to the 
vascular endothelium may result in irrevers-
ible loss of limbal stem cells (LSCs) 3. LSCs are
responsible for maintaining ocular surface 
health by continuous proliferation and
differentiation into corneal epithelial cells 
that are a major part of corneal integrity and 
normal vision 4. Hence, damage to the LSCs 
can lead to disturbance in ocular surface integ-
rity and result in persistent corneal epithelial 
defect, corneal infection, corneal perforation 
and even loss of vision. Proper management 
of LSCD is critical for preventing these
serious complications and improving vision. 
Limbal stem cell transplantation (LSCT) 
is the standard management of total LSCD 
with any cause. Gold standard techniques 
for unilateral and bilateral total LSCD are
conjunctival-limbal autograft (CLAU) and kera-
tolimbal allograft (KLAL), respectively 5. In 
addition, many patients with chemical burn-in-
duced total LSCD develop significant stro-
mal opacification that necessitates lamellar or
penetrating keratoplasty to restore vision 6.
Corneal grafting in these patients should be 
considered as high-risk due to accompanying 
ocular surface abnormalities as well as corne-
al neovascularization 7. Although CLAU and 
KLAL are generally successful in short-term, 
long term visual prognosis depends on the
survival of stem cell and/or corneal graft and
accompanying ocular complications such as 
glaucoma 8; 9. Allograft rejection is the major 
cause of stem cell failure following KLAL10. 
Although CLAU does not harbor the risk of 
allograft rejection, chronic inflammation and 
ocular surface compromise can alter stem cell 
function and eventually lead to CLAU failure in 
long term 11. Furthermore, corneal graft rejection 
and failure is another major complication in both 
auto and allograft procedures 12. Survival of the 
KLAL in the first two years after LSCT has 
been reported to be 77 % to 100 % 13-15. Howev-
er, the long-term survival of KLAL decreases 
after 2 years, especially in patients undergoing 
simultaneous keratoplasty 12; 16; 17. In one study, 
KLAL survival rate was 54.4 % at 1 year, 33.3 
% at 2 years, and 27.3 % at 3 years 18. In unilat-
eral LSCD, CLAU resulted in improvement of 
vision in 35 % to 88 % of cases 19. Long-term sur-
vival of CLAU is reported to be better or equal 
to allogenic LSCT in different studies 5; 20; 21. 
In this retrospective cross-sectional study, we 
report the long-term outcomes of CLAU and 
KLAL in a tertiary referral center.
Patients and Methods
Patients
Records of all patients with chemical burn 
who were referred to the Labbafinejad Medical 
Center, Tehran, Iran, between 2006 and 2016 
and underwent CLAU or KLAL with or with-
out subsequent keratoplasty were reviewed 
retrospectively. 
The study protocol was approved by the ethics 
committee of the Labbafinejad Medical Center 
Clinical Research and Development Unit, Tehran, 
Iran, and adhered to the tenets of declaration of 
Helsinki. Informed written consent for using their 
records for future research purposes was obtained 
from all patients.
Surgical procedures
All procedures were performed by standard 
techniques described elsewhere 10; 22. Briefly, for 
KLAL, fresh globes with intact epithelium and 
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conjunctiva were obtained from the Eye Bank 
of the Islamic Republic of Iran. A 360-degree
corneoscleral rim including 3-mm sclera and 
2-mm cornea was trimmed and thinned 
from the endothelial side as much as
possible to achieve an approximately 100
microns rim containing limbus. In the recipient 
eye, a 360-peritomy was performed and scar
issues were removed. The donor rim was fixed 
to the sclera using 8-0 Vicryl sutures with a
spatulated needle. Then the conjunctiva was
sutured using 10-0 nylon. A soft bandage
contact lens was placed and lateral
tarsorrhaphy was performed. All patients
received systemic immunosuppression 2 weeks 
before until at least 2 years after KLAL. For 
CLAU, 360-degree conjunctival peritomy 
was performed in the recipient's affected eye 
and the scar tissue was removed. Amniotic 
membrane was placed and fixed to the limbus 
and sclera using tangential continuous 10-0 
nylon sutures. Then, 2 pieces of 60-degree 
limbal blocks containing enough conjunctiva 
were harvested from the donor (healthy) eye 
at 6 and 12 o’clock. The donor limbal blocks 
were transferred to the recipient eye and fixed 
at the corresponding superior and inferior
locations at the limbus using separate 10-0
nylon sutures. At the end of the procedure, a soft
bandage contact lens was fitted and lateral
tarsorrhaphy was performed.
Ophthalmic examinations
Relevant data including demographics, date 
of injury, type of chemical agent (acid versus
alkali), date and type of ocular surgeries, acute 
and chronic complications related to chemical 
injury or stem cell/corneal graft were extract-
ed from the patients’ records. Best-corrected
visual acuity (BCVA) was measured by
tumbling E-chart at 6 meters before LSCT 
and at the final examination. Also, slit-lamp
examination was performed at each visit to
assess the degree of LSCD (defined as the
degrees of cornea invaded by conjunctival
epithelium), opacification of the crystalline 
lens (cataract formation), ocular surface
staining by fluorescein, tear-film stabili-
ty (defined by tear-film break-up time and 
tear meniscus height) and graft-related
complications (vascularization, epithelial
defect, rejection or failure). Intraocular
pressure was monitored using Goldmann
applanation tonometer mounted on slit-lamp. 
Dilated fundus examination was performed 
to evaluate the optic nerve head cupping or at-
rophy, retinal detachment and other posterior 
segment complications. In cases with severe 
media opacity, ultrasonography B-scan mode 
was performed for posterior segment evaluation.
The main outcome measures were final 
BCVA and the survival of the limbal stem 
cell graft. Successful limbal stem cell graft 
was defined as stable corneal epithelium
without persistent corneal epithelial defect and
significant superficial vascularization. Su-
perficial corneal vascularization invading 
the central 5mm of cornea and/or presence 
of persistent corneal epithelial defect were 
considered as signs of stem cell graft failure. 
Statistical analysis
All data were analysed using SPSS version 21 
(Armonk, NY: IBM Corp) software. BCVA 
was converted to LogMAR scale for statistical 
analysis. LogMAR for visual acuities less than 
20 / 200 were considered 2.6, 2.7, 2.8 and 
2.9 for counting fingers, hand motion, light
perception and no light perception, respective-
ly. Mean ± SD of the BCVA LogMAR were 
calculated and compared between the initial 
and final visit using paired-samples t-test.
Chi-Square test was used to compare
nonparametric variables. Kaplan-Meier survival 
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analysis was performed to assess stem cell and 
corneal graft survivals. P-values less than 0.05 
were considered statistically significant.
Results
Records of fifty eyes of fifty patients (44 male 
and 6 female) including 24 in CLAU and 26 
in KLAL group who completed at least 12 
months of follow-up were analysed. The mean
age of patients was 39.74 ± 12.68 years and 
the mean follow-up duration was  67.4 ± 47.3 
months. The mean initial BCVA was 2.44 
± 0.81 LogMAR. Table 1 shows the demo-
graphics in each group of patients. Forty 
five eyes (20 eyes from CLAU and  25 eyes 
from KLAL subgroups) underwent optical
penetrating keratoplasty (PKP) in a subsequent 
(20 CLAU and 20 KLAL eyes) or simultane-
ous (5KLAL eyes) procedure. 
In total, final BCVA improved to 1.85
LogMAR (P < 0.001), which showed significant
improvement compared to initial BCVA (2.44 
LogMAR).
The final BCVA was not significantly different 
between CLAU (1.93 LogMAR) and KLAL 
(1.78 LogMAR) subgroups. It was improved 
in 28 cases (13 CLAU and 15 KLAL), stayed
unchanged in 13 cases (6 CLAU and 7 KLAL) 
and worsened in 9 cases (5 CLAU and 4 
KLAL). We did not find any significant
correlation between the type of chemical agent 
and final visual acuity.
The 1-year and 5-year LSCT survival rate for 
all cases was 93.4 % and 62.8 %, respectively. 
It was 100 % and 84.1 % for CLAU and 80.4 
% and 40 % for KLAL subgroups, respectively
(P = 0.037). Figure 1 shows Kaplan-Meier
survival plot of the CLAU and KLAL subgroups.
The overall 1-year and 5-year corneal graft
survival rate was 92.7 % and 41.8 %, respec-
tively. It was 93.3 % and 63.8 % for CLAU and 
92 % and 30.7 % for KLAL subgroups, respec-
tively (P = 0.005). Figure 2 shows Kaplan-Meier
survival plot of the PKP in each subgroup.
Five-year survival rate of LSCT and corneal 
graft in eyes with simultaneous KLAL and 
PKP was 37.5 % and 0 %, respectively. The 
mean interval between PKP and graft failure in 
simultaneous procedures was 30 ± 19.4 months.
Discussion
Our study showed high success rate of LSCT 
in patients with total LSCD due to severe chemical 
injury. Long-term survival of stem cell and corneal 
graft was significantly better in autograft group 
as it was expected. Simultaneous KLAL and 
PKP seems to carry a higher risk of failure of 
both stem cell and corneal grafts compared to 
sequential procedure. There was a difference 
Table 1: Demographic characteristics of patients in CLAU and KLAL groups
CLAU (N = 24) KLAL (N = 26) P value
Age (Mean ± SD) 43.42 ± 13.66 36.54 ± 10.94 0.06
Male/Female Ratio 19/5 25/1 0.09
Agent (Acid : Alkali) 5/19 6/20 0.56
Followup (Months) (Mean ± SD) 63.70 ± 55.70 70.82 ± 38.85 0.60
Initial BCVA LogMAR (Mean ± SD) 2.43 ± 0.79 2.44 ± 0.85 0.96
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 Figure 1: Cumulative survival of the stem cell transplantation in CLAU (blue) and KLAL (green) 
subgroups
Figure 2: Cumulative survival of the corneal graft in CLAU (blue) and KLAL (green) subgroups
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in survival rate between sequential versus
simultaneous procedure but our findings 
might not be reliable because of small sample 
size.
CLAU has been proved to be a safe and effective 
procedure for restoration of limbal stem cells in 
unilateral LSCD 22. In spite of the development 
of new epithelial transplant techniques, in 
unilateral limbal stem-cell deficiency, CLAU 
from a healthy unaffected fellow eye remains 
the best option available for restoration of
corneal phenotype 23. Concurrent amniotic mem-
brane transplantation (AMT) has shown to be 
useful in providing smooth corneal surface for 
epithelial migration and repairing the adnex-
al abnormality (i.e. symblepharon) 22. CLAU 
with AMT provides long-term symptom relief,
improvement in visual acuity and regression of 
superficial corneal vessels in nearly all cases 22. 
However, in a substantial proportion of cases 
with total LSCD, subsequent keratoplasty is 
required to restore vision. We did not observe 
iatrogenic LSCD in the donor eye in our cas-
es. However, donor eye LSCD may develop 
if the donor eye limbus is already altered 24, 
hence one should confirm normal fellow eye 
before considering CLAU. Wylegala et al., 25 
compared outcomes of KLAL, living-related 
conjunctival limbal allograft (lr-CLAL) and 
CLAU in 43, 26 and 21 eyes, respectively with 
a mean follow-up time of 31.2 months (range 
6-72). They found that graft survival rate and 
the regularity of the corneal surface differed
significantly between the allo and autografts 25. 
The 3-year and 6-year graft survival rates were 
76.1 % and 61.9 %, for the autologous transplan-
tation group, and 59.4 % and 46.3 %, for the 
allogeneic transplantation group respectively 
25. However, Barreiro et al., 20 reported that the
midterm (approximately 20 months) survival 
of CLAU was similar to living-related con-
junctival limbal allograft (lr-CLAL). Other 
studies showed that despite the continuous 
administration of systemic immunosuppression, 
the success rate of KLAL declines from 75 % 
to 80 % after 1 year to 50 % after 3 years 
of followup 13-16. Miri et al., 21 reported that 
the long-term survival for CLAU, lr-CLAL 
and KLAL was 100 %, 89 % and 33 %,
respectively. They proposed that this dif-
ference might be due to freshness of 
the donors in CLAU and lr-CLAL and no
rejection-related complications in autograft 21. 
However the survival rate might be worse in 
cases with Stevens - Johnson syndrome (SJS), 
severe dry eye and adnexal abnormality.
Preoperative dry eye has been reported as the 
most important prognostic factor for LSCT 
survival 11. In addition, subsequent or simul-
taneous penetrating keratoplasty might be an 
additional risk factor for stem cell graft fail-
ure, especially in those cases who are known 
to be high-risk grafts due to significant stromal 
bed vascularization and concurrent ocular sur-
face compromise 5; 6; 12; 26. A previous study has 
reported 92 % graft survival at year 1, 77 % 
at year 2, 62 % at year 3, 55 % at year 4, and 
54 % at year 5 after keratoplasty and LSCT 27.
We found a marked difference in long-term 
stem cell and corneal graft survival between 
CLAU and KLAL subgroups. In addition, 
the prognosis was worst in cases who had
simultaneous KLAL and PKP. However, it 
should be noted that this is a retrospective 
study, and therefore the surgical procedure 
was not randomly selected. In addition, the 
relatively small number of subjects in each 
subgroup, especially small number of simulta-
neous procedure makes it difficult to make con-
clusions. The eyes undergoing KLAL might 
have more severe injury than those undergoing 
CLAU. However, the initial and final visual
acuity was comparable between the two
groups. Also, eyes that had combined limbal 
and central graft transplantation might have
had more severe involvement in the corneal
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stroma. Hence, a prospective randomized
study is necessary to draw a final conclusion.
Conclusion
Severe chemical burn is associated with
significant ocular morbidity and long-term
prognosis is poor. Graft survival rate was sig-
nificantly better in conjunctival limbal auto-
graft compared to keratolimbal allograft when
comparing the Long-term outcome of limbal 
stem cell transplantation for management of total 
limbal stem cell deficiency due to chemical burn. 
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